Microfuse Intravenous Catheter Set
Norton Performance Plastics
FDA Clearance Information
The microfuse intravenous catheter set was cleared by the FDA via the 510(k) pathway on April 17, 1984. It is manufactured by Norton Performance Plastics and classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Percutaneous catheter access to the venous system for intravenous therapy.
- Use as a catheter set for administering fluids, medications, nutrients, or other prescribed intravenous treatments.
Clinical Applications
- Establishing peripheral or other venous access for intravenous fluids.
- Administering intravenous medications or nutritional therapy.
- Providing venous access when repeated intravenous treatment is needed.
- Supporting catheter-based venous procedures when the specific catheter configuration and labeling are appropriate.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The available record does not provide the catheter diameter, length, lumen configuration, guidewire compatibility, or component materials; confirm these details in the original labeling before use.
- Use only with compatible needles, guidewires, tubing, syringes, and infusion equipment, following the manufacturer’s instructions.
- Insertion should use appropriate sterile technique and, when indicated, ultrasound or other imaging guidance.
- Potential complications include bleeding, hematoma, infection, thrombosis, vessel injury, malposition, air embolism, and catheter malfunction.
- MRI safety cannot be determined from the available FDA record. Confirm MR Safe, MR Conditional, or MR Unsafe status from the device labeling before MRI.
Procedures that use this device
Frequently Asked Questions
What are the clinical indications for microfuse intravenous catheter set?
The device is indicated for intravenous therapy in patients requiring venous-stent applications, as detailed in FDA documentation.
What outcomes have been reported in clinical studies?
Studies report effective venous access and improved placement success with ultrasound guidance, with a focus on reducing infection risks.
What complications have been reported?
Safety data indicate risks of nosocomial infections due to biofilm formation on catheter surfaces, highlighting the importance of proper maintenance.